ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals Inc (CYCC)

2.01
0.01
( 0.50% )
Updated: 11:43:48

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000373k16k31k
Operating Income -6.56M-5.79M-6.47M-8.85M-7.32M-5.93M-6.85M-5.36M
Pre Tax Income -5.25M-5.56M-6.11M-9M-7.12M-6.03M-6.7M-5.69M
Net Income -4.16M-4.63M-5.15M-7.47M-5.85M-5.5M-6.08M-5.32M
Preferred Dividends -50k-51k-50k-50k-50k-51k-50k-50k
Basic Earnings Per Share (EPS) 00000000
EBIT -5.28M-5.79M-6.45M-8.84M-7.15M-6.04M-6.85M-5.36M
EBITDA -6.55M-5.78M-6.46M-8.84M-7.31M-5.92M-6.84M-5.35M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 843k0150k0000420k
Operating Income -14.15M-9.49M-9.55M-9.68M-10.64M-22.94M-27.66M-25.45M
Pre Tax Income -13.77M-8.46M-8.63M-9.13M-9.68M-22.73M-25.92M-25.55M
Net Income -11.99M-14.85M-7.49M-8.03M-12.42M-19.09M-21.4M-22.76M
Preferred Dividends -200k-201k-201k-201k-201k-201k-201k-201k
Basic Earnings Per Share (EPS) -2.611-1.204-0.584-0.626-1.887-1.807-1.632-1.679
EBIT -14.08M-8.54M-8.87M-9.45M-9.75M-22.79M-26.36M-25.4M
EBITDA -14.05M-9.46M-9.52M-9.66M-10.62M-22.9M-27.62M-25.42M